TrueShares S&P Autocallable Defensive Income ETF
ETFYour view on PAYM

TrueShares S&P Autocallable Defensive Income ETF
ETFTrueSharesSentiment
AUM (USD)
$131.55M
Expense Ratio
0.74%
Holdings
7
Sentiment
Overview for TrueShares S&P Autocallable Defensive Income ETF
- Fund Type
- ETF
- Fund Issuer
- TrueShares
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- December 29, 2025
- Domicile
- US
- Website
- true-shares.com/etf/paym
- Fund Type
- ETF
- Fund Issuer
- TrueShares
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- December 29, 2025
- Domicile
- US
- Website
- true-shares.com/etf/paym
- Fund Type
- ETF
- Fund Issuer
- TrueShares
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- December 29, 2025
- Domicile
- US
- Website
- true-shares.com/etf/paym
About this fund
The Fund seeks to generate moderate monthly income while reducing downside risk. The Fund mainly invests at least 80% of its total net assets in U.S. Treasuries, cash and cash equivalents, and unfunded that provide exposure to a synthetic portfolio of autocallable notes included …
PAYM Stock Price
Key Facts
EquityExpense Ratio
0.74%
AUM
$131.55M
Fund Details
Expense Ratio
0.74%
Assets Under Management
$131.55M
NAV
$25.45 USD
Holdings
7
Average Volume
38.5K
Inception Date
December 29, 2025
Asset Class
Equity
Fund Issuer
TrueShares
Domicile
US
ISIN
US2103225742
CUSIP
210322574
NAV Currency
USD
Expense Ratio
0.74%
Assets Under Management
$131.55M
NAV
$25.45 USD
Holdings
7
Average Volume
38.5K
Inception Date
December 29, 2025
Asset Class
Equity
Fund Issuer
TrueShares
Domicile
US
ISIN
US2103225742
CUSIP
210322574
NAV Currency
USD
Latest headlines and company announcements for this company. Press releases and market coverage, newest first.
News
this company valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.